• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Arimidex (anastrozole) Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

May 2013

Summary View

6.0 ADVERSE REACTIONS

6.2 Post-Marketing Experience
  • hypercalcemia (with or without an increase in parathyroid hormone) added to trigger finger
  • added.....myalgia

NOTE: revised the text throughout the entire patient package insert

 

April 2011

Summary View

 

6 ADVERSE REACTIONS

6.1 Clinical Trials Experience

Other Adverse Reactions

  • ...safety results from ATAC trial...